CDKN2B-AS1 and coronary artery disorder: One CAD risk SNP was associated with altered ANRIL expression in blood, but not with CDKN2A or CDKN2B expression [36], whilst a different CAD risk SNP has been associated with reduced expression of all three genes in peripheral blood T-cells [37].